Cite
Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis
MLA
Douglas Jacoby, et al. “Assessment and Management of the Heightened Risk for Atherosclerotic Cardiovascular Events in Patients with Lupus Erythematosus or Dermatomyositis.” International Journal of Women’s Dermatology, vol. 7, no. 5, Dec. 2021, pp. 560–75. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....00562db519b2c0e1bd7e359e1f1576ec&authtype=sso&custid=ns315887.
APA
Douglas Jacoby, Victoria P. Werth, DeAnna Diaz, Thomas Vazquez, Emily Keyes, Madison Grinnell, & Kevin Jon Williams. (2021). Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis. International Journal of Women’s Dermatology, 7(5), 560–575.
Chicago
Douglas Jacoby, Victoria P. Werth, DeAnna Diaz, Thomas Vazquez, Emily Keyes, Madison Grinnell, and Kevin Jon Williams. 2021. “Assessment and Management of the Heightened Risk for Atherosclerotic Cardiovascular Events in Patients with Lupus Erythematosus or Dermatomyositis.” International Journal of Women’s Dermatology 7 (5): 560–75. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....00562db519b2c0e1bd7e359e1f1576ec&authtype=sso&custid=ns315887.